文献速递神经眼科眼整形与眼眶

进展性甲状腺眼病压迫性视神经病变视野缺损序列的新命名法

A Nomenclature to Describe the Sequence of Visual Field Defects in Progressive Thyroid Eye Disease-Compressive Optic Neuropathy (An American Ophthalmological Society Thesis).
PubMed 文献 · Am J Ophthalmol · 2019-12-13

该研究基于单中心回顾性病历,提出用于描述进展性甲状腺眼病压迫性视神经病变(TED-CON)视野缺损纵向序列的新命名法。在23例患者37眼共234份视野中,下视野缺损最常见,83.8%的眼呈现从1a至3期的可预测进展模式,改善时可见反向顺序。

要点

  • TED-CON视野缺损多始于下视野,按1a、1b、1c、2a、2b、3期可预测进展。
  • 15眼在TED-CON改善时出现视野缺损进展的反向顺序。

核心结论

  • TED-CON所致Humphrey视野缺损最常位于下视野,多呈可预测的进展模式,可归入新的描述性命名系统。

研究设计与样本

  • 单中心回顾性病历复习,纳入继发于TED-CON的进展性Humphrey视野缺损患者,由2名独立评审者将视野缺损分为10类、3期及X期。

主要发现

  • 234份视野中,1a期(小下旁中心暗点)22份(9.4%),1b期(大下旁中心暗点)112份(47.9%),1c期(下水平半侧缺损)11份(4.7%)。
  • 234份视野中,2a期(下水平半侧缺损伴上视野越过水平中线进展)41份(17.5%),2b期(下水平半侧缺损伴上弓形缺损)6份(2.6%),3期(全部丧失)5份(2.1%)。
  • 16.2%的进展模式起源于X期(中心/旁中心、生理盲点扩大和散在缺损)。

关键数值与推荐

  • 1期包括3个严重程度:1a小下旁中心暗点、1b大下旁中心暗点、1c下水平半侧缺损。
  • 2期包括2个严重程度:2a下水平半侧缺损伴上视野越过水平中线进展、2b下水平半侧缺损伴上弓形缺损。
  • 3期为下及上半侧视野完全丧失。

临床怎么用

  • 可用该命名法对TED-CON患者视野缺损进行分期描述,识别下视野起始的 predictable 进展序列。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To create a novel nomenclature to characterize the longitudinal sequence of visual field (VF) defects in patients with progression of thyroid eye disease-compressive optic neuropathy (TED-CON). METHODS: A retrospective review of records from 1 institution identified patients with progressive Humphrey VF defects secondary to TED-CON. The VF defects were analyzed by 2 independent reviewers and classified into 1 of 10 categories, divided into 3 stages that reflect the observed progression pattern, plus a miscellaneous category (stage X). Stage 1 VF defects are the earliest detectable and involve the inferior visual field with 3 levels of severity. Stage 2 VF defects include 2 distinguishable levels of severity and occur as the inferior defects advance above the horizontal midline to involve the superior VF. Stage 3 involves progression of stage 2 VF defects to complete loss of inferior and superior hemifields. RESULTS: Of 234 VFs in 37 eyes of 23 subjects, inferior defects were most common, including stage 1a (small inferior paracentral defect) in 22 of 234 VFs (9.4%), stage 1b (large inferior paracentral defect) in 112 of 234 VFs (47.9%), and stage 1c (inferior altitudinal defect) in 11 of 234 VFs (4.7%). Stage 2a (inferior altitudinal with superior advancement above the horizontal meridian) occurred in 41 of 234 VFs (17.5%), stage 2b (inferior altitudinal with superior arcuate) occurred in 6 of 234 VFs (2.6%), and stage 3 (total loss) occurred in 5 of 234 VFs (2.1%). The longitudinal sequence of VF defects from the 37 eyes of 23 patients was analyzed. Thirty-one of 37 eyes (83.8%) demonstrated a predictable progression pattern from least to more severe: stage 1a, stage 1b, stage 1c, stage 2a, stage 2b, and stage 3. A reverse order of VF defect progression was noted in 15 eyes with improving TED-CON. A minority of progression patterns (16.2%) originated from stage X (central/paracentral, enlarged blind spot, and scatter). CONCLUSIONS: Humphrey VF defects resulting from TED-CON are most often inferior, often have a predictable pattern of progression, and can be categorized into a novel descriptive nomenclature system. NOTE: Publication of this article is sponsored by the American Ophthalmological Society.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Freitag SK, Tanking T. A Nomenclature to Describe the Sequence of Visual Field Defects in Progressive Thyroid Eye Disease-Compressive Optic Neuropathy (An American Ophthalmological Society Thesis). Am J Ophthalmol. 2019. PMID: 31843473. doi:10.1016/j.ajo.2019.12.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。